121 related articles for article (PubMed ID: 3449085)
21. Cytokinetic resistance of Lewis lung carcinoma to cyclophosphamide and the amsacrine derivative CI-921.
Baguley BC; Finlay GJ; Wilson WR
Prog Clin Biol Res; 1986; 223():47-61. PubMed ID: 3809201
[No Abstract] [Full Text] [Related]
22. Nucleic acid binding drugs--XIV. The crystal structure of 1-methyl amsacrine hydrochloride; relationships to DNA-binding ability and anti-tumour activity.
Neidle S; Webster GD; Baguley BC; Denny WA
Biochem Pharmacol; 1986 Nov; 35(22):3915-21. PubMed ID: 3778515
[TBL] [Abstract][Full Text] [Related]
23. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.
Brodie CR; Collins JG; Aldrich-Wright JR
Dalton Trans; 2004 Apr; (8):1145-52. PubMed ID: 15252653
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
[TBL] [Abstract][Full Text] [Related]
25. Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity.
Bacherikov VA; Chou TC; Dong HJ; Zhang X; Chen CH; Lin YW; Tsai TJ; Lee RZ; Liu LF; Su TL
Bioorg Med Chem; 2005 Jun; 13(12):3993-4006. PubMed ID: 15911312
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivatives.
Searcey M; McClean S; Madden B; McGown AT; Wakelin LP
Anticancer Drug Des; 1998 Dec; 13(8):837-55. PubMed ID: 10335263
[TBL] [Abstract][Full Text] [Related]
27. Molecular origins of selectivity in the interaction of amsacrine-4-carboxamide with GC-rich sequences in DNA.
Bailly C; Denny WA; Waring MJ
Anticancer Drug Des; 1996 Dec; 11(8):611-24. PubMed ID: 9022749
[TBL] [Abstract][Full Text] [Related]
28. Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs.
Roy S; Hagen KD; Maheswari PU; Lutz M; Spek AL; Reedijk J; van Wezel GP
ChemMedChem; 2008 Sep; 3(9):1427-34. PubMed ID: 18537202
[TBL] [Abstract][Full Text] [Related]
29. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
Finlay GJ; Wilson WR; Baguley BC
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1695-701. PubMed ID: 2561099
[TBL] [Abstract][Full Text] [Related]
30. Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agents.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
Anticancer Drug Des; 1999 Jun; 14(3):281-9. PubMed ID: 10500503
[TBL] [Abstract][Full Text] [Related]
31. Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.
Atwell GJ; Baguley BC; Finlay GJ; Rewcastle GW; Denny WA
J Med Chem; 1986 Sep; 29(9):1769-76. PubMed ID: 3755758
[TBL] [Abstract][Full Text] [Related]
32. Novel Thiazine Substituted 9-Anilinoacridines: Synthesis, Antitumour Activity and Structure Activity Relationships.
Kalirajan R; Gaurav K; Pandiselvi A; Gowramma B; Sankar S
Anticancer Agents Med Chem; 2019; 19(11):1350-1358. PubMed ID: 30961512
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage.
Kapuriya N; Kapuriya K; Zhang X; Chou TC; Kakadiya R; Wu YT; Tsai TH; Chen YT; Lee TC; Shah A; Naliapara Y; Su TL
Bioorg Med Chem; 2008 May; 16(10):5413-23. PubMed ID: 18450456
[TBL] [Abstract][Full Text] [Related]
34. Relationship between the structure of analogues of amsacrine and their degree of cross-resistance to adriamycin-resistant P388 leukaemia cells.
Baguley BC; Finlay GJ
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):205-10. PubMed ID: 3356208
[TBL] [Abstract][Full Text] [Related]
35. The possible role of electron-transfer complexes in the antitumour action of amsacrine analogues.
Baguley BC
Biophys Chem; 1990 Apr; 35(2-3):203-12. PubMed ID: 2204443
[TBL] [Abstract][Full Text] [Related]
36. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
37. Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma.
Baguley BC; Finlay GJ
J Natl Cancer Inst; 1988 Apr; 80(3):195-9. PubMed ID: 3346911
[TBL] [Abstract][Full Text] [Related]
38. Antitumour activity of novel 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives.
Wesselinova D; Neykov M; Kaloyanov N; Toshkova R; Dimitrov G
Eur J Med Chem; 2009 Jun; 44(6):2720-3. PubMed ID: 19249137
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of macrocyclic taxane analogues.
Tarrant JG; Cook D; Fairchild C; Kadow JF; Long BH; Rose WC; Vyas D
Bioorg Med Chem Lett; 2004 May; 14(10):2555-8. PubMed ID: 15109650
[TBL] [Abstract][Full Text] [Related]
40. [Cytotoxicity and interaction of amsacrine derivatives with topoisomerase II: role of the 1' substitute on the aniline nucleus].
René B; Fossé P; Khélifa T; Jacquemin-Sablon A; Bailly C
Bull Cancer; 1997 Oct; 84(10):941-8. PubMed ID: 9435795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
